| 1 |
nuclear factor of activated T cells c1
(617 times)
|
Biochemistry
(84 times)
|
RANKL (287 times)
TRAP (173 times)
BMMs (101 times)
|
2003 Calcineurin is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-2.
|
| 2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
(17 times)
|
Biochemistry
(8 times)
|
RANKL (12 times)
TRAP (5 times)
BMMs (4 times)
|
2005 MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
|
| 3 |
nuclear factor of activated T cells calcineurin-dependent 1
(3 times)
|
Pharmacology
(1 time)
|
RANKL (2 times)
ERK (1 time)
JmjC (1 time)
|
2012 JMJD5, a Jumonji C (JmjC) domain-containing protein, negatively regulates osteoclastogenesis by facilitating NFATc1 protein degradation.
|
| 4 |
NF for activation of T cells c1
(1 time)
|
Allergy and Immunology
(1 time)
|
AP-1 (1 time)
NF (1 time)
|
2005 Fos/AP-1 proteins in bone and the immune system.
|
| 5 |
NFAT cytoplasmic-1
(1 time)
|
Chemistry
(1 time)
|
COX-2 (1 time)
CREB (1 time)
NFAT (1 time)
|
2017 TNFalpha Increases RANKL Expression via PGE₂-Induced Activation of NFATc1.
|
| 6 |
nuclear factor 1
(1 time)
|
Neoplasms
(1 time)
|
BC (1 time)
BM (1 time)
MALAT1 (1 time)
|
2020 Denosumab inhibits MCF-7 cell line-induced spontaneous osteoclastogenesis via the RANKL/MALAT1/miR-124 axis.
|
| 7 |
nuclear factor calcineurin-dependent 1
(1 time)
|
Clinical Medicine
(1 time)
|
RANK (1 time)
|
2021 A novel modified RANKL variant can prevent osteoporosis by acting as a vaccine and an inhibitor.
|
| 8 |
nuclear factor of T cell c1
(1 time)
|
Chemistry
(1 time)
|
OPCs (1 time)
OSCC (1 time)
RANKL (1 time)
|
2019 A Novel, Tumor-Induced Osteoclastogenesis Pathway Insensitive to Denosumab but Interfered by Cannabidiol.
|
A Search Service for Abbreviation / Long Form